{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:19:31Z","timestamp":1793787571155,"version":"4.6.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ajo.2021.03.007","type":"journal-article","created":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T17:19:08Z","timestamp":1615828748000},"page":"220-229","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Quality of Life in Primary Open-Angle Glaucoma and Cataract: An Analysis of VFQ-25 and OSDI From the iStent inject\u00ae Pivotal Trial"],"prefix":"10.1016","volume":"229","author":[{"given":"Thomas W.","family":"Samuelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inder Paul","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake K.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4498-215X","authenticated-orcid":false,"given":"Heather","family":"Falvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Chan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Odom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6122-2083","authenticated-orcid":false,"given":"David","family":"McSorley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Jay","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ajo.2021.03.007_bib0001","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ajo.2010.09.020","article-title":"Vision-specific quality-of-life research: a need to improve the quality","volume":"151","author":"Lamoureux","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2021.03.007_bib0002","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4103\/0974-9233.56222","article-title":"Cataract surgery to lower intraocular pressure","volume":"16","author":"Berdahl","year":"2009","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2021.03.007_bib0003","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/ICL.0000000000000544","article-title":"Ocular surface disease and glaucoma medications: a clinical approach","volume":"45","author":"Zhang","year":"2019","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.ajo.2021.03.007_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2011.05.033","article-title":"Ocular surface disease and quality of life in patients with glaucoma","volume":"153","author":"Skalicky","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.007_bib0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1477-7525-1-75","article-title":"Vision related quality of life and topical glaucoma treatment side effects","volume":"1","author":"Nordmann","year":"2003","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ajo.2021.03.007_bib0006","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/112067210901900409","article-title":"Dry eye syndrome-related quality of life in glaucoma patients","volume":"19","author":"Rossi","year":"2009","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.007_bib0007","series-title":"Becker-Shaffer's Diagnosis and Therapy of the Glaucomas","first-page":"598","author":"Hoskins","year":"1989"},{"key":"10.1016\/j.ajo.2021.03.007_bib0008","series-title":"Complications of glaucoma therapy","first-page":"283","author":"Sherwood","year":"1990"},{"issue":"5","key":"10.1016\/j.ajo.2021.03.007_bib0009","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0002-9394(00)00901-6","article-title":"Glaucoma filtering bleb dysesthesia","volume":"131","author":"Budenz","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.007_bib0010","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(18)32213-X","article-title":"Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (light): a multicentre randomised controlled trial","volume":"393","author":"Gazzard","year":"2019","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.ajo.2021.03.007_bib0011","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jamaophthalmol.2017.4574","article-title":"Development of an 18-item measure of symptom burden in patients with glaucoma from the Collaborative Initial Glaucoma Treatment Study's Symptom and Health Problem Checklist","volume":"135","author":"Musch","year":"2017","journal-title":"JAMA Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2021.03.007_bib0012","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0161-6420(00)00624-2","article-title":"Quality of life in newly diagnosed glaucoma patients: The Collaborative Initial Glaucoma Treatment Study","volume":"108","author":"Janz","year":"2001","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2021.03.007_bib0013","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ophtha.2018.09.034","article-title":"United Kingdom Glaucoma Treatment Study Investigators. Are patient self-reported outcome measures sensitive enough to be used as end points in clinical trials?: Evidence from the United Kingdom Glaucoma Treatment Study","volume":"126","author":"Jones","year":"2019","journal-title":"Ophthalmology"},{"issue":"10052","key":"10.1016\/j.ajo.2021.03.007_bib0014","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(16)30956-4","article-title":"Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial","volume":"388","author":"Azuara-Blanco","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ajo.2021.03.007_bib0015","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.ophtha.2019.03.006","article-title":"Prospective, randomized, controlled pivotal trial of an ab interno implanted trabecular micro-bypass in primary open-angle glaucoma and cataract: two-year results","volume":"126","author":"Samuelson","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2021.03.007_bib0016","series-title":"The National Eye Institute 25-Item Visual Function Questionnaire (VFQ-25)","author":"Mangione","year":"2000"},{"key":"10.1016\/j.ajo.2021.03.007_bib0017","series-title":"Ocular Surface Disease Index (OSDI) Administration and Scoring Manual","author":"Walt","year":"2004"},{"key":"10.1016\/j.ajo.2021.03.007_bib0018","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archopht.118.5.615","article-title":"Reliability and validity of the Ocular Surface Disease Index","volume":"118","author":"Schiffman","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.007_bib0019","unstructured":"Food and Drugs Administration (FDA). Guidance for Industry Patient- Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. December 2009. Available at http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM193282.pdf."},{"issue":"3","key":"10.1016\/j.ajo.2021.03.007_bib0020","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11136-012-0175-x","article-title":"Acaster S, the Industry Advisory Committee of International Society for Quality of Life Research (ISOQOL). Methods for interpreting change over time in patient-reported outcome measures","volume":"22","author":"Wyrwich","year":"2013","journal-title":"Qual Life Res"},{"key":"10.1016\/j.ajo.2021.03.007_bib0021","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","article-title":"Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation","volume":"41","author":"Norman","year":"2003","journal-title":"Med Care"},{"issue":"4","key":"10.1016\/j.ajo.2021.03.007_bib0022","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0197-2456(89)90005-6","article-title":"Measurement of health status. Ascertaining the minimal clinically important difference","volume":"10","author":"Jaeschke","year":"1989","journal-title":"Control Clin Trials"},{"issue":"7","key":"10.1016\/j.ajo.2021.03.007_bib0023","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1167\/iovs.13-13683","article-title":"Estimating minimally important differences for two vision-specific quality of life measures","volume":"55","author":"Gillespie","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.ajo.2021.03.007_bib0024","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/eye.2015.70","article-title":"Cataract extraction and patient vision-related quality of life: a cohort study","volume":"29","author":"Javed","year":"2015","journal-title":"Eye (Lond)"},{"issue":"4","key":"10.1016\/j.ajo.2021.03.007_bib0025","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/ceo.12454","article-title":"Cataract and quality of life in patients with glaucoma","volume":"43","author":"Skalicky","year":"2015","journal-title":"Clin Exp Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2021.03.007_bib0026","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ogla.2019.07.005","article-title":"Identifying outcomes that are important to patients with ocular hypertension or primary open-angle glaucoma: a qualitative interview study","volume":"2","author":"Le","year":"2019","journal-title":"Ophthalmol Glaucoma"},{"issue":"4","key":"10.1016\/j.ajo.2021.03.007_bib0027","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1167\/iovs.08-2575","article-title":"Evaluating clinical change and visual function concerns in drivers and nondrivers with glaucoma","volume":"50","author":"Janz","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2021.03.007_bib0028","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1097\/ICO.0b013e3181c325b2","article-title":"Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications","volume":"29","author":"Fechtner","year":"2010","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.ajo.2021.03.007_bib0029","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40135-013-0009-1","article-title":"Dry eye disease: impact on quality of life and vision","volume":"1","author":"Uchino","year":"2013","journal-title":"Curr Ophthalmol Rep"},{"issue":"3","key":"10.1016\/j.ajo.2021.03.007_bib0030","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ajo.2006.11.060","article-title":"Impact of dry eye syndrome on vision-related quality of life","volume":"143","author":"Miljanovi\u0107","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2021.03.007_bib0031","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1167\/iovs.11-9094","article-title":"Assessment of vision-related quality of life in dry eye patients","volume":"53","author":"Li","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2021.03.007_bib0032","doi-asserted-by":"crossref","first-page":"184-189 e3","DOI":"10.1016\/j.ajo.2013.02.019","article-title":"The impact of dry eye disease on visual performance while driving","volume":"156","author":"Deschamps","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"10.1016\/j.ajo.2021.03.007_bib0033","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0161-6420(97)30125-0","article-title":"Relation between signs and symptoms of dry eye in the elderly. A population-based perspective","volume":"104","author":"Schein","year":"1997","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ajo.2021.03.007_bib0034","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1167\/iovs.03-0270","article-title":"The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity","volume":"44","author":"Begley","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"10.1016\/j.ajo.2021.03.007_bib0035","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/01.ico.0000133997.07144.9e","article-title":"The lack of association between signs and symptoms in patients with dry eye disease","volume":"23","author":"Nichols","year":"2004","journal-title":"Cornea"},{"issue":"2","key":"10.1016\/j.ajo.2021.03.007_bib0036","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00417-016-3550-4","article-title":"Is there a change in the quality of life comparing the micro-invasive glaucoma surgery (MIGS) and the filtration technique trabeculectomy in glaucoma patients?","volume":"255","author":"Pahlitzsch","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.007_bib0037","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajo.2017.04.003","article-title":"Quality-of-life outcomes from a randomized clinical trial comparing antimetabolites for intermediate, posterior, and panuveitis","volume":"179","author":"Niemeyer","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2021.03.007_bib0038","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.1167\/iovs.12-10223","article-title":"Moving from PROMs to POEMs for glaucoma care: a qualitative scoping exercise","volume":"53","author":"Somner","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2021.03.007_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2019.100801","article-title":"Beyond intraocular pressure: optimizing patient-reported outcomes in glaucoma","volume":"76","author":"Fenwick","year":"2020","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.ajo.2021.03.007_bib0040","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1167\/iovs.16-19458","article-title":"Activity limitation in glaucoma: objective assessment by the Cambridge Glaucoma Visual Function Test","volume":"57","author":"Skalicky","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2021.03.007_bib0041","doi-asserted-by":"crossref","first-page":"2476e2484","DOI":"10.1016\/j.ophtha.2013.07.020","article-title":"The relationship between better-eye and integrated visual field mean deviation and visual disability","volume":"120","author":"Arora","year":"2013","journal-title":"Ophthalmology"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421001203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939421001203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:44:11Z","timestamp":1762080251000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939421001203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":41,"alternative-id":["S0002939421001203"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2021.03.007","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality of Life in Primary Open-Angle Glaucoma and Cataract: An Analysis of VFQ-25 and OSDI From the iStent inject\u00ae Pivotal Trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2021.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}